SKYMAX, incorporated in 2001 is a All Together Truly Indian Pharmaceutical Company, poised to achieve outstanding market presence in area of operation, offering specialty products and delivery systems of world class quality, to achieve the motto of Approaching Sky Heights for Maximal Health Care. 

The Architects of SKYMAX are a team comprising of young Pharma technocrats, management professionals and energetic marketing professionals who bring to the company a combination of Vision, R & D Capabilities, Technological Know How, Quality Innovation and Manufacturing Expertise to the Organization. With totally young & enthusiastic board of directors it intends to be a global pharmaceutical company by 2022. With total dedication towards maximal health care, company shall be able to make greater contribution to the health quality of life of the ailing humanity around the globe. 

The company's range of products and delivery systems extends across different Segment such as Antibiotics, Anti Inflammatory, Anti Emetic, Antimalarial, Anti Diarrhoeal, Anti Protozoaland specialized products for Gastroenterelogist, Gynecologists, Orthopaedic& Cardio -diabetics Doctors. 

Skymax is focused on increasing the momentum in the ethical business in its key markets through organic and inorganic growth routes. It continues to evaluate acquisition opportunities in India, emerging and developed markets to accentuate its business and competitiveness. The Company’s growth is well spread across geographies with near equal focus on developed and emerging markets. Skymax has entered into specialitytherapeutic segments like Anti-biotics, Anti-malarial, Cardio -diabetics, Analgesics & Antipyretics, Anti-Inflammatory, Gastro Intestinal, Antifungal, Erectile Dysfunction, Corticosteroid, Allergic Disorders, Gynaec, Antipsychotics. These new growth areas will add significant depth to its existing product pipeline.